Spindle Biotech
Toronto
About Spindle Biotech
Spindle Biotech is commercializing a proprietary RNA polymerase for large-scale mRNA vaccine production. Recent advances in mRNA technology have shown the growing importance of synthetic RNA in biological systems due to its desirable transient property.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: M&A
- Last round: Seed (Sep 2022)
- Website: spindle.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/spindle-biotech-2709232 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.